Tempus Labs and Eric Lefkofsky’s Fight Against Cancer

The disease cancer has been characterized as being a tricky antagonist that mimics the body’s normal functions so it can grow undisturbed. Because the body doesn’t recognize that there is a problem, it does not attack the cancer and it continues to grow unabated. Eric Lefkofsky is using Tempus Labs to devise successful ways to stop this complex disease.

Tempus Labs uses data to improve the way cancer patients are diagnosed and treated. The data is gathered from comprehensive cancer centers and top academic institutions. Eric Lefkofsky hopes to use Tempus to disseminate the cancer data to every doctor that has a cancer patient so that treatments can be design around each individual patient in a customized manner.

After the data garnered from the treatment of each cancer patient is stored in a central location it will be easier to disseminate the information to the important parties. The patients’ treatment data is stored in their medical records, but it has not been clinically coordinated for each type or cancer and most importantly, the information has not been accessible by physicians treating cancer patients.

Tempus was created to be central location for all this cancer treatment data. By bringing molecular data and clinical data together, Lefkofsky hopes Tempus will result in personalized, effective and more informative cancer treatments. Tempus is meant to contain data from every area of cancer treatments including molecular, therapeutic, clinical and the outcome response.

Molecular data is the patients’ DNA and RNA. RNA is the Ribonucleic acid, a polymeric molecule that is a part of various biological activities such as coding, decoding, regulation, and the work of genes. DNA is useful because it is considered to be an important element in developing personalized medicine for cancer patients.

The centralized location of such a vast amount of data will enable the fight for cancer to become more targeted and focused. Using big data analytics cancer treatments can be more effectively designed and administered. Currently, Tempus Labs can analyze data for 50,000 patients annually. Ultimately Tempus Labs will be able to take miscellaneous cancer treatment records and compile them in an orderly and annotated manner for ease of access. Lefkofsky’s Tempus will continue its use of clinical records, molecular data, DNA, RNA, etc. to compile a complete history of cancer treatments, their successes and failures to eventually supply all the necessary data needed to fight cancer successfully.

Eric Lefkofsky’s  Social Media: www.facebook.com/eplefkofsky/